SEATTLE, August 15, 2023 (Newswire.com)
-
In the lead-up to Mother's Day 2023, Seattle plastic surgeon Dr. Javad Sajan's practice, Allure Esthetic Plastic Surgery, collected donations for mothers experiencing homelessness in the community. This included physical donations in the office and monetary donations directly to the Zera Foundation, the partnering nonprofit organization.
With collection boxes at all three locations, Dr. Sajan offered five free units of Botox to anyone who donated two or more items to the drive. Allure Esthetic frequently works with the 501c3 nonprofit, the Zera Foundation to make a difference in the lives of families in transition and underprivileged populations.
In a video about the fundraiser, Javad Sajan, MD says, "We're so excited to partner with our community to help people who are going through a difficult transition in life." Allure Esthetic also hosts other fundraising events throughout the year such as a Thanksgiving Food Drive and School Supplies Drive.
On July 22nd, Dr. Sajan hand-delivered the donations to Mary's Place, a shelter and organization that supports women and families, in Seattle. The donations consisted of diapers, wipes, and other items necessary for mothers and children of all ages. All donations stay within the community and uplift women and children in need.
About Javad Sajan, MD: Javad Sajan, MD is a plastic surgeon in Seattle, Washington. His practice Allure Esthetic Plastic Surgery provides plastic surgery and life-saving gender affirming surgery to patients from all around the world. Allure Esthetic and Javad Sajan, MD regularly participate in the community through item collection drives and fundraisers that benefit families and children in the Great Seattle area. Find Dr. Sajan, Allure Esthetic, and their community service efforts on Instagram @realdrseattle.
Updates to Tempo's Manufacturing Execution System and Connected Manufacturing Network Drive Greater Efficiency and Scalability
Visual Step Builder Develop complex procedure workflows through a click-and-drag visual flow of steps for easier process design for scientists.
JERSEY CITY, N.J., August 15, 2023 (Newswire.com)
-
Apprentice, which helps life science manufacturers get treatments to patients faster by providing one platform to turn molecules into medicine, announced today a major release to its Tempo Manufacturing Cloud, focused on extending product capabilities for modern commercial manufacturing.
The 7.0 Release deepens Tempo's existing features in its Manufacturing Execution System (MES) that support commercial production and adds a new product, the Connected Manufacturing Network (CMN), that creates a connected digital network across internal and external sites.
Deepening Manufacturing Execution System (MES) Capabilities
"We want to help our customers navigate today's complex manufacturing environment as drug therapies become more specialized and scalability becomes more important," said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. "With the 7.0 release, we're building the technological innovation that will directly reduce cost, increase speed, and maximize yield of commercial manufacturing so that lifesaving medicines get to patients in need."
In addition to 30+ new features and enhancements, seven key new capabilities standout:
Visual step builder: Develop complex procedure workflows through a click-and-drag visual flow of steps for easier process design for scientists.
Kitting: Use and consume predefined resource sets instead of searching for individual components in order to streamline procedures and save valuable time.
Automatic step execution: Execute actions within a procedure step, such as calculations or scanning equipment, in addition to creating steps that connect to other equipment or even other systems with in-step integration.
Remote Assistance: Adapt to constant change during execution and drive faster reviews with real-time embedded video conferencing from a procedure run.
Conditional Step Navigation: Guide an operator to one of several procedure step options using 'if', 'if then', or 'else' statements based on the result of the previous step.
New integrations: Start batch runs directly from an External DCS to support automated batch runs.
Web execution: Gain greater operational flexibility with the new ability to execute from your web browser, in addition to Tempo's iPad and wearable headset.
The Connected Manufacturing Network
The 7.0 release also includes the new CMN product. Tempo's CMN enables you to drive value at the site-level, the enterprise-level, and across external partners. To achieve this, CMN brings together four powerful capabilities:
Product Lifecycle Data: Consolidate data for each stage of a drug's lifecycle in one place.
Enterprise Recipe Management: Optimize enterprise recipe management across environments and sites.
External Manufacturing Collaboration: Ditch email and calls for automated communications.
Tech Transfer: Quickly and easily move all your master resources and data.
These key tools allow you to coordinate the materials, equipment, recipes, and personnel needed to plan, execute, test, and release a batch from one shared system to accelerate the end-to-end drug production lifecycle.
Launching Tempo with the Team
Apprentice held a virtual launch event on Tuesday with 100+ attendees highlighting the new commercial functionality and the success of its recently released CMN package.
Event sessions covered everything from Apprentice's more sophisticated commercial manufacturing capabilities to its new quarterly release cadence, additional quality updates, and the formation of its partner program.
"We have a clear vision for building a product that can support the future of commercial manufacturing and connect enterprise-wide operations across internal and external sites and teams," said Jean Barmash, CTO at Apprentice. "We will continue to up-level our product capabilities and standardize our approach so that our customers can rely on one system for accelerating critical drug production."
About Apprentice
Apprentice helps life science manufacturers get therapeutics to patients faster by providing one platform to turn molecules into medicine. Our Tempo Manufacturing Cloud accelerates the end-to-end drug product lifecycle by connecting together distributed teams and sites, helping them execute better on the shop floor, and optimizing their operations through enterprise-wide visibility. From preclinical benchtop to large-scale commercial manufacturing, Tempo keeps your global teams connected, empowered, and in sync.
With $207M in funding, a 3.4x growth YoY rate, and 218% net customer retention, Apprentice is a trusted partner to modernize your operations and change the way drugs are made in your facility. Learn how leading companies like Synthego and Bristol Myers Squibb are using Tempo to scale from drug discovery to patient delivery faster at www.apprentice.io.
Elevating Community Health: August Marks National Immunization Month, a Time to Raise Awareness and Promote Lifesaving Vaccinations. LevelUp MD Urgent Care Encourages Keeping Immunization Records Up-to-Date.
BROOKLYN, N.Y., August 15, 2023 (Newswire.com)
-
LevelUp MD Urgent Care is proud to join the nationwide observance of National Immunization Awareness Month (NIAM), a critical initiative that underscores the paramount importance of vaccinations for individuals of all ages. Throughout August, we are committed to raising awareness about the crucial role vaccines play in safeguarding public health and maintaining the well-being of our communities.
Vaccinations stand as one of the most impactful achievements in modern medicine, offering unparalleled protection against preventable diseases. National Immunization Month serves as a vital reminder that vaccines are not only a personal responsibility but a collective effort to build immunity, reduce illness, and promote longevity. By administering routine vaccinations, we contribute to the health and resilience of our society as a whole.
"At LevelUp MD Urgent Care, we recognize the significance of immunizations as a cornerstone of preventive healthcare. National Immunization Awareness Month provides us with an opportunity to amplify the importance of vaccines and their role in keeping communities thriving," stated Dr. Jonathan Gamss, Chief Medical Director at LevelUp MD Urgent Care.
Our commitment to public health is evident through the array of vaccinations we offer at our conveniently located facilities in New York and New Jersey. Our comprehensive range of vaccines includes:
TDAP
Hepatitis B
Meningitis
MMR (Measles, Mumps, Rubella)
Varicella
MPOX (Mumps, Polio, Rubella)
COVID-19 (Ages 6 months and up)
Flu (Age 6 months and up)
"During National Vaccine Awareness Month and well into the future, our mission remains clear: to inform, inspire, and empower. Through educational initiatives, accessible resources, and collaborative engagement, we are actively working to fortify the health of our communities. By emphasizing the significance of vaccinations, we stand united in our commitment to building a healthier and more resilient tomorrow for everyone," says Rey Bolic, Director of Marketing and Community Outreach at LevelUp MD Urgent Care.
LevelUp MD Urgent Care boasts multiple accessible locations, making quality healthcare readily available to residents of New York and New Jersey:
Bloomfield, NJ
Emerson, NJ
Passaic, NJ
Crown Heights, Brooklyn, NY
East Flatbush, Brooklyn, NY
Park Slope, Brooklyn, NY
Williamsburg, Brooklyn, NY
The Hub, Bronx, NY
Norwood, Bronx, NY
Forest Hills, Queens, NY
During National Immunization Awareness Month and beyond, LevelUp MD Urgent Care remains dedicated to being a steadfast partner in promoting health and advocating for preventive care. By offering a variety of vaccines across our locations, we stand committed to protecting the well-being of our communities and inspiring a future where preventable diseases are conquered.
A New American Heart Association CPR Certification School Has Just Opened in Brentwood, CA. This School Offers Daily Classes to the Public in CPR, BLS, ACLS, PALS, and CPR and First Aid.
Safety Training Seminars' new Brentwood CPR Training School offers a comprehensive range of courses for medical professionals, including CPR, BLS, ACLS, and PALS. Each course provides an innovative blend of online learning resources and on-site skills testing, ensuring that participants are fully prepared to handle life-threatening emergencies. After the training, students will immediately receive the official American Heart Association certification card.
ACLS Courses offer initial and renewal certification in American Heart Association Advanced Cardiovascular Life Support, providing participants with the skills and knowledge needed to respond to cardiopulmonary arrest or other cardiovascular emergencies.
CPR & First Aid Classes are designed for a wide variety of participants, such as teachers, babysitters, childcare care providers (EMSA), supervisors, and more. Students will learn the proper techniques for administering CPR to infants, children, and adults, as well as how to use AEDs, treat bleeding, respond to seizures, and more. After completing the course, all students will receive the official American Heart Association CPR and First Aid certification.
BLS CPR courses provide new and renewal certification, helping attendees identify and respond to life-threatening emergencies. After attending this course, students will receive the official American Heart Association BLS certification card, which is valid for two years.
PALS Courses are designed to meet the criteria for initial or renewal certification and teach participants how to recognize and respond to emergencies in infants and children. PALS stands for Pediatric Advanced Life Support.
Safety Training Seminars has been providing crucial courses for certification and lifesaving training since 1989. The woman-owned company has 45 locations across Northern California, and they offer the most affordable, flexible training, with the latest resources and equipment. With their new Brentwood CPR office, Safety Training Seminars is committed to equipping Contra Costa residents with the skills and confidence to react quickly in emergency situations. To learn more about CPR and First Aid training in Brentwood, Antioch, and other locations across California, visit www.bayareacpr.org.
Contact Information:
Danielle Bell
General Manager [email protected]
415-437-1600
TORONTO, August 15, 2023 (Newswire.com)
-
StageZero Life Sciences ("StageZero" or the "Company") (TSX: SZLS), a vertically-integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced its second quarter financial results for the three and six months ended June 30, 2023, and will provide an update on its business operations.
For the quarter ended June 30, 2023 the Company generated revenue of $0.793 million. This is a small increase over Q1 2023 but continues the trajectory established post-COVID of Quarterly gains. Net loss narrowed to ($0.401) with a ($0.00) basic and diluted loss per common share.
"This has been a quarter of negotiating and concluding key partnerships that we expect to contribute strongly to our growth during the second half of this year," said James Howard-Tripp, Chairman & CEO of StageZero Life Sciences. "A major focus is on self-funded employers where we believe Aristotle and AVRT uniquely position us, the insurance groups that back them, but also to position ourselves for new, exciting initiatives in Preventative Health. Our partners reflect this," he added.
Strategic partnerships with laboratory groups and clinical groups will increase the number of employers, clinics and individual patients who can readily access StageZero's Aristotle test and AVRT/TREAT programs. Individuals and Employers are increasingly looking for better health outcomes and early detection notably contributes to a better outcome. In addition, it contributes to lower costs which, for Employers, is a driving metric for their bottom line.
Operational Update: will be provided during Analyst Call.
Q2 2023 Financial Results
All amounts are expressed in U.S. dollars unless otherwise stated and results are reported in accordance with International Financial Reporting Standards.
The Company generated $1.6 million in cancer testing and treatment revenue for the six months ended June 30, 2023 as compared to COVID testing-related $2.3 million in revenue for the six months ended June 30, 2022 and realized a net loss of $2.2 million, or $0.02 basic and diluted loss per common share as compared to a $1.9 million net loss for the six months ended June 30, 2022, or $0.02 basic and diluted loss per common share.
The Company generated $0.793 million in cancer testing and treatment revenue for the three- months ended June 30, 2023, compared to COVID testing-related revenue of $0.998 million for the three months ended June 30, 2022. Net loss was $0.4 million, or $0.00 loss per fully diluted common share in Q2, 2023 as compared to a $1.3 million net loss, or $0.01 loss per fully diluted common share in Q2, 2022.
The Company's financial statements and management's discussion and analysis are available on www.sedar.com.
Analyst and Investor Call Event Date: Tuesday August 15, 2023 Time: 8:30 am ET Webcast Link:https://www.gowebcasting.com/12674 Conference Call Numbers Canada/USA TF: 1-800-319-4610 Toronto Toll: +1-416-915-3239 International Toll: +1-604-638-5340
About StageZero Life Sciences, Ltd. StageZero Life Sciences, Ltd. is a company innovating on the forefront of screening for the early detection of cancer. StageZero combines its proprietary liquid biopsy multi-cancer detection test, Aristotle®, with Physician led clinical programs; offering patients a unique treatment combination not found anywhere else.
Aristotle®, is the first ever mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle® uses mRNA technology to identify the molecular signatures of multiple cancer types. Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. It is an individualized therapeutic approach which seeks to simultaneously target multiple metabolic cancer pathways and is intended for adjunctive administration alongside standard-of-care cancer therapy. The aim is to restrict cancer cell energy supply and use.
The COC Protocol program is managed by a multi-disciplinary team that is overseen by an Oncologist and includes Nurse Practitioners and Metabolic Specialists. CareOncology Clinics also offers AVRT a Physician-Led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease.
Aristotle® is processed at the Company's clinical laboratory, StageZero Life Sciences, Inc., a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. StageZero Life Sciences trades on the Toronto Stock exchange under the symbol SZLS and on the OTCQB under the symbol SZLSF.
Forward-Looking Statements
This press release contains forward-looking statements identified by words such as "expects", "will" and similar expressions, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company's actual events to differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.
Batgirl continues to loom over DC, with the scrapped movie’s logo making its way onto a Blue Beetle standee among released titles.
The scrapping of Batgirl from the DC schedule last year was a major blow to comic book movie fans. Despite the studio’s track record, there was plenty of interest around that project: Leslie Grace in the title role, Brendan Fraser as the key villain and Michael Keaton as Batman. Instead, 2022 and 2023 had Black Adam, a Shazam! sequel and The Flash, which at least did give us Keaton. But we all wanted to see how DC would handle Batgirl – and now curiosity has piqued yet again, as the logo remains on a promotional standee for Blue Beetle. OK, now they’re just rubbing it in!
In an image posted to Twitter (uh, we mean X) this week, a user showed off a Blue Beetle standee while also pointing out that “if you enhance on the bottom of the stand there’s this cool little easter egg…” along with a skull emoji. That easter egg is the logo for the discarded Batgirl, featured alongside those for other DC movies like The Batman, Aquaman and more that were or will be released. You can see the logo and standee below:
DC obviously would have approved and created this promotion well in advance – especially noted with the accompanying “Check out all of the DC films coming soon!” claim, which is still odd since they knew Blue Beetle was coming out after the advertised movies – but that Batgirl lingers among those that the studio had actual faith in is both a bit amusing and infuriating. One can only imagine how Batgirl directors Adil El Arbi and Bilall Fallah will feel about this…
Ironically, Blue Beetle is far from generating positive buzz and is currently tracking to have a $17 million opening later this month, meaning it would have the worst opening of a DCEU movie to date. Blue Beetle comes to theaters on August 18th, with the next DCEU entry, Aquman and the Lost Kingdom arriving on December 20th.
Do you think DC really has anything to lose by releasing Batgirl on a streaming service? How do you think Blue Beetle will fare at the box office?
IRVINE, Calif., August 15, 2023 (Newswire.com)
-
BrainStorm Education is thrilled to announce the Kickstarter launch of its revolutionary STEM Kits, designed to empower young learners with hands-on experiences in Science, Technology, Engineering, and Mathematics. These innovative kits aim to spark creativity and critical thinking, and a deep passion for learning, setting the stage for the next generation of innovators, engineers, and problem solvers.
BrainStorm STEM Kits are meticulously crafted to engage students from various age groups, making learning a dynamic and interactive adventure. Whether at home, in the classroom or as part of an after-school program, these kits provide a diverse range of activities that nurture exploration and experimentation all while developing a solid foundation in core STEM concepts.
Key features of BrainStorm STEM Kits include:
Hands-On Learning: Each kit is packed with high-quality materials and step-by-step instructions, ensuring that learners can jump into exciting projects right away. From building simple machines to exploring circuitry, these kits enable kids to turn theoretical knowledge into practical applications.
Curriculum-Aligned: BrainStorm Education has collaborated with educators and subject matter experts to align the STEM Kits with modern curricula. This ensures that the kits seamlessly complement classroom learning, reinforcing concepts in an engaging manner.
Diversity of Topics: The STEM kits are aligned to NGSS Science Standards and cover a wide array of STEM subjects, allowing learners to explore different disciplines and discover their interests.
Innovation and Creativity: BrainStorm STEM Kits encourage students to think outside the box and develop innovative solutions to real-world problems. Through open-ended activities, learners cultivate their creative-thinking skills and develop confidence in their abilities.
Parent and Teacher Support: BrainStorm Education provides comprehensive resources for parents and educators, including video tutorials, lesson plans, and additional learning materials. This makes it easy for teachers to integrate the kits into their classrooms and for parents to facilitate meaningful learning experiences at home.
"We believe that hands-on exploratory learning is the cornerstone of effective STEM education," says Darren Jones, founder and CEO of BrainStorm STEM Education. "Our mission is to spark curiosity and empower young minds to become active learners, critical thinkers, and innovative problem solvers. With BrainStorm STEM Kits, we're excited to provide children with the tools they need to thrive in an increasingly technology-driven world."
BrainStorm Education is a California-based educational company dedicated to providing innovative learning solutions that inspire curiosity and foster a love for STEM learning in students of all ages.
Verified user reviews place ChiroFusion among the Top Chiropractic EHR platforms on Capterra.
BOCA RATON, Fla., August 15, 2023 (Newswire.com)
-
ChiroFusion announced today that Capterra, the world's leading software discovery and reviews platform, has recognized ChiroFusion as the Best Ease of Use Chiropractic EHR software platform. Ease of use is a fundamental concept that describes how easily users can utilize a product. The engineering team at ChiroFusion continues to dedicate significant time and resources to optimize ease of use while maximizing functionality. This ongoing investment has established ChiroFusion as one of the most user-friendly practice management platforms to learn and use.
"We deeply value our engaged and vocal user community that openly shares their experiences," said Damon Cozamanis D.C., President of ChiroFusion. "User reviews offer valuable insights to potential buyers of our chiropractic practice management solution, and their constructive feedback drives our innovation. This recognition from Capterra is particularly meaningful as it is based on genuine user ratings. There is no better measure of success."
Within Capterra, a repository of over 300,000 verified user reviews spanning 400+ software categories exists. The "Best" badges distill these reviews to honor the top-rated products within each category, assisting users in evaluating software options and facilitating well-informed purchasing decisions. ChiroFusion was also named a Top Performer in the 2022 Chiropractic Software Shortlist by Capterra.
With over 560 reviewers giving ChiroFusion an average rating of 4.7 out of 5 stars, the following comments about ChiroFusion were shared:
"The system is easy to learn, set up, and use. The SOAP notes are very quick to complete. The scheduler is fast and intuitive. I wish we had switched to ChiroFusion years ago!" - Alana B., Office Manager
"Onboarding new patients is extremely simple for us using the digital intake forms and demographic prompts." - Eliza S., Front Desk Staff
"We've found ChiroFusion easy to learn and use. Support is readily available whenever we have a question." - Katsia R., Chiropractic Billing Specialist
ChiroFusion has developed an acclaimed practice management software that empowers chiropractors to optimize office efficiency and financial performance. Known for its intuitive and clear interface, ChiroFusion offers an unmatched array of features, including online patient scheduling and payment, appointment reminders, digital intake forms, compliant SOAP notes, and comprehensive billing and revenue management - all seamlessly integrated within a single web-based software solution.
In 2016, ChiroFusion was named to the Inc 500 list of fastest-growing private companies in America, achieving 1,545% growth over a three-year period. For more information about ChiroFusion, visit www.chirofusionsoftware.com.
Contact Information:
Damon Cozamanis, D.C.
President / CEO [email protected]
(877) 210-3230
Dermadry is back with its fifth annual edition of the Dermadry Hyperhidrosis Scholarship. The contest is open to students who suffer from hyperhidrosis, a medical condition characterized by excessive sweating that affects approximately 1 in 20 people worldwide. The student with the most compelling story will win a $2,000 Cash Prize.
MONTREAL, August 15, 2023 (Newswire.com)
-
Dermadry, the leading provider of hyperhidrosis treatment solutions, is excited to announce the launch of its fifth annual Dermadry Hyperhidrosis Scholarship. This scholarship program aims to support students worldwide who suffer from hyperhidrosis, a medical condition characterized by excessive sweating that affects approximately 1 in 20 people globally.
Hyperhidrosis can have a significant impact on a person's quality of life, affecting their confidence, social interactions, and overall well-being. Dermadry is committed to raising awareness about this condition and supporting those who are affected by it.
"We are thrilled to launch the fifth edition of the Dermadry Hyperhidrosis Scholarship," said Mathieu Mireault, co-founder of Dermadry. "Our goal is to provide financial assistance to students who are dealing with hyperhidrosis, helping them pursue their educational dreams without the burden of excessive sweating holding them back."
To apply for the scholarship, students are asked to record themselves discussing their experience with hyperhidrosis and how it impacts their studies and everyday life. The application form can be found at this link. Submissions close on Aug. 20 at 11:59 p.m. EDT. The scholarship is open to students worldwide who are currently enrolled in a post-secondary educational program.
The winner of the scholarship will receive a prestigious 1st Prize of $2,000 USD. Additionally, there are other enticing rewards to be won, including a 2nd Prize of $1,000 USD and a 3rd Prize of $500 USD. The top 3 winners will also each receive a Dermadry Total, a hyperhidrosis treatment device. As a special incentive, the seven runner-ups will each receive a Dermadry Total to help them during their academic journey.
But that's not all. Dermadry wants to reward every applicant. Each participant will receive an exclusive discount code, granting them a remarkable 70% reduction on their Dermadry order.
A panel of experts from Dermadry will select 10 finalists from the submissions. Five finalists' entries will be chosen by members of the Dermadry team, and the remaining five will be determined by public voting on Dermadry's social media platforms.
Dermadry is excited to support students with hyperhidrosis through its annual scholarship program. By providing financial assistance and raising awareness about this condition, Dermadry hopes to empower students to pursue their educational goals without the limitations of excessive sweating.
About Dermadry: Dermadry is a leading provider of hyperhidrosis treatment solutions. Our innovative iontophoresis machine helps individuals suffering from excessive sweating find relief and regain their confidence. With a commitment to raising awareness and supporting those affected by hyperhidrosis, Dermadry continues to make a positive impact in the lives of many.
Contact Information:
Mathieu Mireault
Marketing Director [email protected]
AURORA, Ill., August 15, 2023 (Newswire.com)
-
Mental Health Technologies (MHT) is excited to announce its partnership with leading healthcare solutions provider Meditab Software and its all-inclusive EHR system, Intelligent Medical Software (IMS).
MHT is an award-winning SaaS company that provides automated behavioral health assessments directly to patients on behalf of their healthcare provider. MHT's intuitive software sends assessments directly to the patient's email or phone, convenient for the patient and a time-saving measure for the physician.
A commanding software on its own, MHT increases its dominance by partnering with Meditab's Intelligent Medical Software (IMS), one of the country's most respected EHR systems. Meditab services over 41,000 healthcare professionals, 1,600 clinics, and 40 specialties.
This collaboration brings advanced resources to medical professionals by streamlining patient assessments with a sophisticated EHR, practice management, billing, and all-encompassing office management program into one intelligent and seamless system. Combining these industry-leading software systems automates time-consuming workflows, removing manual administrative intervention.
Dr. Peyman Palavan, Medical Director at Broadway Medical Center and client of both parties, says, "The facilitation of these companies brings a cutting-edge technology to the medical field. Their integration is going to provide a lot of relief to busy medical practices and create a synergy like we've never seen." He adds, "I'm excited to be a part of this partnership and have already seen how much our office and patient experience has improved."
A compelling aspect of this partnership is seeing MHT's patent-pending SmarTest in use. This technology uses progressive intellect alongside historical patient data to determine when and how an individual should be tested for various mental health conditions. SmarTest can base its decisions on patient information such as age, gender, or other demographics. Each clinic or provider group can define its own system of rules for how they want SmarTest to work.
The MHT and Meditab integration offers clinicians:
Improved patient outcomes - MHT sends patients their assessments beforehand, allowing for more thoughtful and honest answers. This benefit guides clinicians to make a more accurate diagnosis and treatment plan.
Automated referrals - MHT sends referrals for patients that need behavioral health assistance directly to their partner provider. This is predetermined based on criteria that the clinicians set up and requires no administrative intervention from the referring provider.
Configured follow-ups - Through SmarTest's intelligent design, clinicians determine how they would like to follow up with subsequent testing based on test results or demographics.
Saved time - Results are automatically uploaded into IMS once the patient completes their screening with no manual work.
Increased revenue - This collaboration automates data collection on your behalf and incorporates billing within the same flawless system, creating an environment where the provider can focus on patient interaction to determine the best treatment protocol.
Feedback - MHT and Meditab provide clients with superb customer service and work to innovate the latest technology based on their needs.
Contact Information:
Ernie Wallerstein
MHT CEO [email protected]
630-240-0323
